| Filed On | Filing |
|---|---|
| 12 Nov 2026 |
Form 4: Caveney Brian J, EVP, Pres of BLS, CMO & CSO
Sold 2,000 shares ($744K) |
| 05 Nov 2026 |
Form 4: Vaughn Bryan T, EVP and President, Diagnostics
Sold 306 shares ($108K) |
| 03 Nov 2026 |
Form 4: Parham Richelle P, Director
Sold 1,078 shares ($389K) |
| 03 Nov 2026 |
Form 4: Oyegunwa Akinbolade, EVP, CIO & CTO
Received 370 shares by exercise or conversion · Gave up 118 shares to cover exercise price or tax ($42K) |
| 03 Nov 2026 |
Form 4: Vaughn Bryan T, EVP and President, Diagnostics
Received 500 shares by exercise or conversion · Gave up 194 shares to cover exercise price or tax ($69K) |
| 03 Sep 2026 |
Form 4: Oyegunwa Akinbolade, EVP, CIO & CTO
Granted 750 Restricted Stock Unit |
| 03 Sep 2026 |
Form 4: Meltzer Jonathan C, EVP, COO
Granted 900 Restricted Stock Unit |
| 03 Sep 2026 |
Form 4: Vaughn Bryan T, EVP and President, Diagnostics
Granted 1,500 Restricted Stock Unit |
| 03 Sep 2026 |
Form 4: Caveney Brian J, EVP, Pres of BLS, CMO & CSO
Granted 3,000 Restricted Stock Unit |
| 18 Aug 2026 |
Form 4: Anderson Kerrii B, Director
Sold 3,000 shares ($954K) |
| 12 Aug 2026 |
Form 4: Schechter Adam H, Director
Sold 4,669 shares ($1.5M) |
| 06 Aug 2026 |
Form 4: Summy Amy B., EVP, Chief Marketing Officer
Sold 924 shares ($283K) |
| 05 Aug 2026 |
Form 4: Wilkinson Peter J, SVP, Chief Accounting Officer
Sold 1,420 shares ($439K) · Received 1,338 shares by exercise or conversion ($280K) |
| 06 Jul 2026 |
Form 4: Kyle Kathryn W, EVP, Chief Legal Officer
Received 256 shares by exercise or conversion · Gave up 73 shares to cover exercise price or tax ($20.7K) · Sold 92 shares ($26.3K) |
| 06 Jul 2026 |
Form 4: Vaughn Bryan T, EVP and President, Diagnostics
Received 327 shares by exercise or conversion · Gave up 93 shares to cover exercise price or tax ($26.4K) · Sold 234 shares ($67K) |
| 10 Jun 2026 |
Form 4: Kyle Kathryn W, EVP, Chief Legal Officer
Sold 762 shares ($201K) |
| 13 May 2026 |
Form 4: Schechter Adam H, Director
Sold 5,903 shares ($1.5M) |
| 30 Mar 2026 |
Form 4: Schechter Adam H, Director
Received 58,470 shares as a grant or award · Gave up 26,106 shares to cover exercise price or tax ($7.01M) |
| 30 Mar 2026 |
Form 4: Graham Anita Z, EVP, CHRO
Received 6,604 shares as a grant or award · Gave up 2,879 shares to cover exercise price or tax ($773K) |
| 30 Mar 2026 |
Form 4: Schroeder Mark S, EVP, Pres Diagnostics & COO
Received 12,272 shares as a grant or award · Gave up 6,068 shares to cover exercise price or tax ($1.63M) |
Loading...